AST SpaceMobile: New Glenn Gives Hope, Manufacturing Should Follow (Rating Upgrade)

AST SpaceMobile was upgraded to strong buy with a $140-per-share fair value, despite recent share weakness and execution delays. Manufacturing issues have pushed satellite launches back; intermittent U.S. service remains targeted for end-2026, while full coverage depends on launch cadence. The analyst views concerns over SpaceX’s spectrum acquisition as an overreaction, citing ASTS’s MNO partnerships and limited direct competition.

Analysis

The central risk is a widening gap between partnership validation and deliverable network capacity: MNO agreements have limited value until ASTS demonstrates repeatable satellite production, launches, and service quality. Manufacturing slippage therefore threatens not just timing but the credibility of the deployment curve—and could raise funding requirements if milestones move out. Verify cash runway, planned capex, launch-slot commitments, and the terms and economics of partner agreements before underwriting the $140 fair-value estimate; that figure is an analyst view, not an independently established floor.

Near term, the upgrade may support sentiment, but the next 1–3 months hinge on verifiable manufacturing and launch milestones rather than another partnership announcement. Through end-2026 and beyond, successful cadence could make ASTS a strategic complement to terrestrial networks; failure would leave it exposed to fixed costs and better-capitalized alternatives. SpaceX’s spectrum position is not automatically bearish for ASTS: it may validate market value while also intensifying competition for spectrum, launch capacity, and customer attention. Regulatory access and the actual commercial terms of any spectrum use remain key unknowns.

Contrarian framing: the bullish case may underweight execution compounding—each delay can push service revenue out and weaken negotiating leverage—while the bearish case may overread spectrum headlines before competitive deployment is demonstrated. No high-conviction trade without current valuation, liquidity, and milestone detail.

Key Decisions for Investors

• Treat ASTS as a milestone-driven speculative position, not a partnership-led growth compounder. If initiating, scale only after independently verifiable manufacturing progress and a credible launch schedule; avoid sizing off the $140 estimate alone.
• Alert: track cash runway, capex and funding plans, launch-slot availability, satellite production yields, and the commercial economics behind MNO agreements. Deterioration in any of these would invalidate the deployment thesis even if partnerships remain intact.
• Do not short ASTS solely on the SpaceX spectrum news. Reassess only if regulatory developments or demonstrated competing service materially impair ASTS’s spectrum access, launch cadence, or partner economics.
• Falsification markers: repeated schedule resets, weaker-than-expected service milestones, or evidence that funding needs rise materially would favor reducing exposure; sustained production and launch execution would support revisiting the long thesis.